skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis

Frontiers in immunology, 2023-01, Vol.14, p.1102126-1102126 [Peer Reviewed Journal]

Copyright © 2023 Hu, Xie, Li and Zhang. ;Copyright © 2023 Hu, Xie, Li and Zhang 2023 Hu, Xie, Li and Zhang ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2023.1102126 ;PMID: 36776893

Full text available

Citations Cited by
  • Title:
    Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis
  • Author: Hu, Jiyun ; Xie, Shucai ; Li, Wenchao ; Zhang, Lina
  • Subjects: biomarker ; Biomarkers ; Brain Diseases - diagnosis ; Brain Diseases - etiology ; Humans ; Immunology ; meta-analysis ; outcome ; Prognosis ; S100 Calcium Binding Protein beta Subunit ; S100B ; Sepsis - complications ; Sepsis - diagnosis ; sepsis-associated encephalopathy ; Sepsis-Associated Encephalopathy - diagnosis
  • Is Part Of: Frontiers in immunology, 2023-01, Vol.14, p.1102126-1102126
  • Description: In sepsis, brain dysfunction is known as Sepsis-associated encephalopathy (SAE), which often results in severe cognitive and neurological sequelae and increases the risk of death. Our systematic review and meta-analysis aimed to explore the diagnostic and prognostic value of serum S100 calcium-binding protein B (S100B) in SAE patients. We conducted a systematic search of the databases PubMed, Web of Science, Embase, Cochrane databases, CNKI, VIP, and WFSD from their inception dates until August 20, 2022. A Meta-analysis of the included studies was also performed using Review Manager version 5.4 and Stata16.0. This meta-analysis included 28 studies with 1401 serum samples from SAE patients and 1591 serum samples from no-encephalopathy septic (NE) patients. The Meta-Analysis showed that individuals with SAE had higher serum S100B level than NE controls (MD, 0.49 [95% CI (0.37)-(0.60), Z =8.29, < 0.00001]), and the baseline level of serum S100B in septic patients with burn was significantly higher than average (1.96 [95% CI (0.92)-(2.99), Z =3.71, P < 0.0002]) In addition, septic patients with favorable outcomes had lower serum S100B levels than those with unfavorable outcomes (MD, -0.35 [95% CI (-0.50)-(-0.20), Z =4.60, < 0.00001]). Our Meta-Analysis indicates that higher serum S100B level in septic patients are moderately associated with SAE and unfavorable outcomes (The outcomes here mainly refer to the mortality). The serum S100B level may be a useful diagnostic and prognostic biomarker of SAE.
  • Publisher: Switzerland: Frontiers Media S.A
  • Language: English
  • Identifier: ISSN: 1664-3224
    EISSN: 1664-3224
    DOI: 10.3389/fimmu.2023.1102126
    PMID: 36776893
  • Source: Geneva Foundation Free Medical Journals
    Open Access: PubMed Central
    MEDLINE
    ROAD: Directory of Open Access Scholarly Resources
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait